Article thumbnail

TRPC channel modulation in podocytes—inching toward novel treatments for glomerular disease

By Shafic El Hindi and Jochen Reiser

Abstract

Glomerular kidney disease is a major healthcare burden and considered to represent a sum of disorders that evade a refined and effective treatment. Excellent biological and genetic studies have defined pathways that go awry in podocytes, which are the regulatory cells of the glomerular filter. The question now is how to define targets for novel improved therapies. In this review, we summarize critical points around targeting the TRPC6 channel in podocytes

Topics: Educational Review
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:3098353
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2000). Evaluation and management of proteinuria